Lobbying activity

Q2

LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for SAVARA INC.

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for REGENXBIO INC.

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q2

LMH STRATEGIC SOLUTIONS for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $230,000.00 income

Pharmacy, Medicare/Medicaid

View → Q2

LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $150,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000.00 income

Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for ARDELYX, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income

Health Issues, Pharmacy

View → Q2

AEGIS LLC for TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income

Pharmacy

View → Q2

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues

View → Q2

PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $9,000.00 income

Pharmacy

View → Q2

MAD GLOBAL STRATEGY for ADNEURIS THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · Senate · $15,000.00 income

Pharmacy

View → RR

BGR GOVERNMENT AFFAIRS for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Virginia

Pharmacy

View → Q2

REPUBLIC CONSULTING, LLC for IQVIA

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $60,000.00 income

Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues

View → RR

ALLERGY & ASTHMA NETWORK for ALLERGY & ASTHMA NETWORK

2nd Quarter (Apr 1 - June 30) 2026 · Virginia

Education, Government Issues, Medicare/Medicaid, Pharmacy

View → RR

MAD GLOBAL STRATEGY for ADNEURIS THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey

Health Issues, Pharmacy

View → Q3

THE OUTLAW GROUP for SENTRY DATA SYSTEMS

3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · $30,000.00 income

Health Issues, Pharmacy

View → RR

MERCURY PUBLIC AFFAIRS, LLC for KNOA PHARMA LLC

2nd Quarter (Apr 1 - June 30) 2026 · Connecticut

Pharmacy

View → RR

CAPITOL COUNSEL LLC for CURIUM

2nd Quarter (Apr 1 - June 30) 2026 · Missouri

Pharmacy

View → RR

DJP SOVEREIGNTY ADVISORS for DJP SOVEREIGNTY ADVISORS

2nd Quarter (Apr 1 - June 30) 2026 · Indiana

Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Trade (domestic/foreign)

View → RA

POLITICAL CAPITAL, LLC for STOKES PHARMACY

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey

Pharmacy

View → 4A

KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Taxation/Internal Revenue Code, Defense, Health Issues, Medicare/Medicaid

View → Q1

THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · $16,000.00 income

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy

View →